Enzon Oncaspar Gains First-Line Leukemia Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Pegaspargase allows for a more convenient dosing regimen than Merck's Elspar, the current standard of care for acute lymphoblastic leukemia, FDA says.